Expression of WNT-5a and ROR2 correlates with disease severity in osteosarcoma

KK UnniOsteosarcoma of boneJ Orthop Sci3287294199810.1007/s007760050055

VO LewisWhat’s new in musculoskeletal oncologyJ Bone Joint Surg Am91154615562009

H WafaRJ GrimerSurgical options and outcomes in bone sarcomaExpert Rev Anticancer Ther6239248200610.1586/14737140.6.2.23916445376

PA MeyersCL SchwartzMD KrailoOsteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival – a report from the Children’s Oncology GroupJ Clin Oncol266336382008

H YaoE AshiharaT MaekawaTargeting the Wnt/β-catenin signaling pathway in human cancersExpert Opin Ther Targets158738872011

J SylvieC EllenV KrisThe role of Wnt in cell signaling and cell adhesion during early vertebrate developmentFront Biosci1723522366201121622181

CC ClarkI CohenI EichstetterLA CannizzaroJD McPhersonJJ WasmuthRV IozzoMolecular cloning of the human proto-oncogene Wnt-5A and mapping of the gene (WNT5A) to chromosome 3p14–p21Genomics182492601993

T PukropC BinderThe complex pathways of Wnt 5a in cancer progressionJ Mol Med (Berl)86259266200810.1007/s00109-007-0266-217952396

SL McDonaldA SilverThe opposing roles of Wnt-5a in cancerBr J Cancer101209214200910.1038/sj.bjc.660517419603030

J DejmekA DejmekA SäfholmA SjölanderT AnderssonWnt-5a protein expression in primary Dukes B colon cancers identifies a subgroup of patients with good prognosisCancer Res6591429146200510.1158/0008-5472.CAN-05-171016230369

N KremenevskajaR von WasielewskiAS RaoC SchöflT AnderssonG BrabantWnt-5a has tumor suppressor activity in thyroid carcinomaOncogene2421442154200510.1038/sj.onc.120837015735754

M KurayoshiN OueH YamamotoExpression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasionCancer Res661043910448200610.1158/0008-5472.CAN-06-235917079465

E BlancD GoldschneiderS Douc-RasyJ BénardG RaguénezWnt-5a gene expression in malignant human neuroblastsCancer Lett228117123200510.1016/j.canlet.2004.11.06115925444

I OishiH SuzukiN OnishiThe receptor tyrosine kinase Ror2 is involved in non-canonical Wnt-5a/JNK signalling pathwayGenes Cells8645654200310.1046/j.1365-2443.2003.00662.x12839624

K MoriokaC TanikawaK OchiOrphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcomaCancer Sci10012271233200910.1111/j.1349-7006.2009.01165.x19486338

WF EnnekingSS SpanierMA GoodmanA system for the surgical staging of musculoskeletal sarcomaClin Orthop Relat Res418200310.1097/01.blo.0000093891.12372.0f14612624

CL HuangD LiuJ NakanoWnt-5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor – an expression in non-small-cell lung cancerJ Clin Oncol2387658773200516314637

XH LiuMH PanZF LuExpression of Wnt-5a and its clinicopathological significance in hepatocellular carcinomaDig Liver Dis40560567200810.1016/j.dld.2007.12.01118294932

J SchlessingerCell signaling by receptor tyrosine kinaseCell103211225200010.1016/S0092-8674(00)00114-811057895

AR AfzralS JefferyOne gene, two phenotypes: ROR2 mutations in autosomal recessive Robinow syndrome and autosomal dominant brachydactyly type BHum Mutat22111200310.1002/humu.1023312815588

AJ MikelsR NussePurified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor contextPLoS Biol4e115200610.1371/journal.pbio.004011516602827